CALVES CHRONICALLY IMPLANTED WITH A TOTAL ARTIFICIAL-HEART AS A PHARMACOLOGICAL MODEL

被引:0
|
作者
EVERETT, SD
PANTALOS, GM
GOLDENBERG, IF
LONG, JW
ROBISON, PD
WHITE, RK
LANDA, MS
SHAW, WJ
OLSEN, DB
机构
[1] UNIV UTAH,DEPT SURG,DIV ARTIFICIAL ORGANS,SALT LAKE CITY,UT 84112
[2] MINNEAPOLIS HEART INST FDN,MINNEAPOLIS,MN
来源
关键词
TOTAL ARTIFICIAL HEART; PHARMACOLOGICAL MODEL; VASCULAR RESPONSE; INOTROPIC DRUGS;
D O I
10.1177/039139889101401206
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Pharmacological therapy for congestive heart failure includes drugs that have both inotropic and vasoactive effects, although it is sometimes difficult to differentiate between the two effects. An animal with an implanted total artificial heart (TAH) allows the investigation of the vascular effect of these drugs in the absence of the effect on the myocardium. An advantage of the TAH model is its sensitivity to changes in right and left ventricular preload and afterload. Four instrumented TAH calves were given vasoactive drugs and the response was compared to control. Epinephrine, dopamine, isoproterenol, and nitroprusside were selected because of the predictability of their responses. Epinephrine caused a significant increase in systemic vascular resistance (SVR), and dopamine caused a significant increase in Pulmonary vascular resistance (PVR) and Isoproterenol caused a significant decrease in PVR. TAH implanted calves can thus serve as a pharmacological model to study the vascular response, which may be useful in investigation of new agents with inotropic and vascular effects.
引用
收藏
页码:775 / 780
页数:6
相关论文
共 50 条
  • [21] THE USE OF AN ARTIFICIAL PERICARDIUM WITH A TOTAL ARTIFICIAL-HEART
    DEPAULIS, R
    RIEBMAN, JB
    DELEUZE, P
    MOHAMMAD, FS
    BURNS, GL
    MOREA, M
    OLSEN, DB
    [J]. JOURNAL OF CARDIOVASCULAR SURGERY, 1990, 31 (02): : 202 - 208
  • [22] THE USE OF AN ARTIFICIAL PERICARDIUM WITH A TOTAL ARTIFICIAL-HEART
    DEPAULIS, R
    RIEBMAN, JR
    DELEUZE, P
    BURNS, GL
    OLSEN, DB
    [J]. ARTIFICIAL ORGANS, 1987, 11 (04) : 295 - 295
  • [23] VASCULAR COMPLIANCE STUDIES IN AWAKE TOTAL ARTIFICIAL HEART IMPLANTED CALVES
    VAKAMUDI, AK
    HONGO, T
    KAKU, K
    AKUTSU, T
    [J]. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 1978, 24 : 606 - 615
  • [24] THE ROSTOCK TOTAL ARTIFICIAL-HEART (TAH)
    REDING, R
    KLINKMANN, H
    BENAD, G
    URBASCEK, W
    HUTH, J
    NOEL, D
    SEIDEL, H
    LANGE, G
    KALKOWSKI, H
    EHRENTRAUT, W
    RINKE, W
    [J]. LANGENBECKS ARCHIV FUR CHIRURGIE, 1981, 355 : 649 - 649
  • [25] CLINICAL USE OF THE TOTAL ARTIFICIAL-HEART
    DEVRIES, WC
    ANDERSON, JL
    JOYCE, LD
    ANDERSON, FL
    HAMMOND, EH
    JARVIK, RK
    KOLFF, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (05): : 273 - 278
  • [26] WORLD SYMPOSIUM ON THE TOTAL ARTIFICIAL-HEART
    JACOBS, G
    [J]. ARTIFICIAL ORGANS, 1980, 4 (01) : 68 - 68
  • [27] INFECTION IN TOTAL ARTIFICIAL-HEART RECIPIENTS
    MURRAY, KD
    HUGHES, S
    BEARNSON, D
    OLSEN, DB
    [J]. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 1983, 29 : 539 - 545
  • [28] A RETROSPECTIVE STUDY OF 9 CALVES SURVIVING 5 MONTHS ON THE PNEUMATIC TOTAL ARTIFICIAL-HEART
    HASTINGS, WL
    AARON, JL
    DENERIS, J
    KESSLER, TR
    PONS, AB
    RAZZECA, KJ
    OLSEN, DB
    KOLFF, WJ
    [J]. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 1981, 27 : 71 - 76
  • [29] BIOCHEMICAL AND IMMUNOLOGICAL STUDIES IN CALVES LIVING OVER 3 MONTHS WITH A TOTAL ARTIFICIAL-HEART
    CIDL, K
    DOSTAL, M
    VASKU, J
    NECAS, J
    DOBSAK, P
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1992, 15 (02): : 120 - 125
  • [30] MECHANICAL ASPECTS OF THE TOTAL ARTIFICIAL-HEART
    UNGER, F
    ALBES, J
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 140 (10-11) : 290 - 293